Monthly Return of Equity Issuer on Movements in Securities
For the month ended
(dd/mm/yyyy) :29/02/2020
To : Hong Kong Exchanges and Clearing Limited
Name of Issuer | Union Medical Healthcare Limited (the "Company") | ||||||||||||||
Date Submitted | 05 Mar 2020 | ||||||||||||||
I. Movements in Authorised Share Capital | |||||||||||||||
1. Ordinary Shares | |||||||||||||||
(1) Stock code : 2138 | Description : | Ordinary Shares | |||||||||||||
Authorised share | |||||||||||||||
No. of ordinary | Par value | capital | |||||||||||||
shares | (HK$) | (HK$) | |||||||||||||
Balance at close of preceding month | 38,000,000,000 | 0.00001 | 380,000.00 | ||||||||||||
Increase/(decrease) | Nil | Nil | |||||||||||||
Balance at close of the month | 38,000,000,000 | 0.00001 | 380,000.00 | ||||||||||||
(2) Stock code : | N/A | Description : | N/A | ||||||||||||
Par value | Authorised share | ||||||||||||||
No. of ordinary | (State | capital | |||||||||||||
shares | currency) | (State currency) |
Balance at close of preceding month
Increase/(decrease)
Balance at close of the month
Page 1 of 13
2. Preference Shares
Stock code : | N/A | Description : | N/A | ||||||||||
No. of | Par value | Authorised share | |||||||||||
preference | (State | capital | |||||||||||
shares | currency) | (State currency) | |||||||||||
Balance at close of preceding month | |||||||||||||
Increase/(decrease) | |||||||||||||
Balance at close of the month | |||||||||||||
3. Other Classes of Shares | |||||||||||||
Stock code : | N/A | Description : | N/A | ||||||||||
No. of other | Par value | Authorised share | |||||||||||
classes of | (State | capital | |||||||||||
shares | currency) | (State currency) | |||||||||||
Balance at close of preceding month | |||||||||||||
Increase/(decrease) | |||||||||||||
Balance at close of the month | |||||||||||||
Total authorised share capital at the end of the month | HK$380,000.00 | ||||||||||||
(HK$) : |
Page 2 of 13
II. Movements in Issued Share Capital
No. of ordinary shares | No of preference | No. of other | ||||||||||||||||||||||||||||||||
(1) | (2) | shares | classes of shares | |||||||||||||||||||||||||||||||
Balance at close of | ||||||||||||||||||||||||||||||||||
preceding month | 985,247,448 | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
Increase/ (decrease) | ||||||||||||||||||||||||||||||||||
during the month | 30,000 | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
Balance at close of the | ||||||||||||||||||||||||||||||||||
month | 985,277,448 | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
III. Details of Movements in Issued Share Capital | ||||||||||||||||||||||||||||||||||
Share Options (under Share Option Schemes of the Issuer) | ||||||||||||||||||||||||||||||||||
Particulars of share | No. of new shares | No. of new shares | ||||||||||||||||||||||||||||||||
option scheme | of issuer issued | of issuer which may | ||||||||||||||||||||||||||||||||
including EGM | during the month | be issued pursuant | ||||||||||||||||||||||||||||||||
approval date | Movement during the month | pursuant thereto | thereto as at close | |||||||||||||||||||||||||||||||
(dd/mm/yyyy) and | of the month | |||||||||||||||||||||||||||||||||
class of shares | ||||||||||||||||||||||||||||||||||
issuable | Granted | Exercised | Cancelled | Lapsed | ||||||||||||||||||||||||||||||
1.Share Option | ||||||||||||||||||||||||||||||||||
Scheme | ||||||||||||||||||||||||||||||||||
adopted | ||||||||||||||||||||||||||||||||||
on | ||||||||||||||||||||||||||||||||||
(19/02/2016) | ||||||||||||||||||||||||||||||||||
5,522,500 | ||||||||||||||||||||||||||||||||||
Ordinary shares | Nil | 30,000 | Nil | Nil | 30,000 | |||||||||||||||||||||||||||||
(Remark 1-15) | ||||||||||||||||||||||||||||||||||
(Note 1) | ||||||||||||||||||||||||||||||||||
2. N/A | ||||||||||||||||||||||||||||||||||
(Note 1) | ||||||||||||||||||||||||||||||||||
3. | N/A | |||||||||||||||||||||||||||||||||
( | / / | ) | ||||||||||||||||||||||||||||||||
shares | ||||||||||||||||||||||||||||||||||
(Note 1) | ||||||||||||||||||||||||||||||||||
Total A. | (Ordinary shares) | 30,000 | ||||||||||||||||||||||||||||||||
(Preference shares) | N/A | |||||||||||||||||||||||||||||||||
(Other class) | N/A | |||||||||||||||||||||||||||||||||
Total funds raised during the month from exercise of | ||||||||||||||||||||||||||||||||||
options (HK$) | $99,125 | |||||||||||||||||||||||||||||||||
Page 3 of 13
Warrants to Issue Shares of the Issuer which are to be Listed
No. of new | No. of new | |||||
shares of | shares of | |||||
issuer | issuer which | |||||
issued | may be | |||||
during the | issued | |||||
Nominal value | month | pursuant | ||||
Currency | at close of | Exercised | Nominal value | pursuant | thereto as at | |
Description of warrants | of nominal | preceding | during the | at close of the | thereto | close of the |
(Date of expiry - dd/mm/yyyy) | value | month | month | month | month |
1. N/A
( / / ) Stock code (if listed) Class of shares issuable (Note 1) Subscription price EGM approval date (if applicable) (dd/mm/yyyy)
2. N/A
( / / ) Stock code (if listed) Class of shares issuable (Note 1) Subscription price EGM approval date (if applicable) (dd/mm/yyyy)
3. N/A
( / / ) Stock code (if listed) Class of shares issuable (Note 1) Subscription price EGM approval date (if applicable) (dd/mm/yyyy)
4. N/A
( / / ) Stock code (if listed) Class of shares issuable (Note 1) Subscription price EGM approval date (if applicable) (dd/mm/yyyy)
( | / | / | ) | |||
( | / | / | ) | |||
( | / | / | ) | |||
( | / | / | ) |
Total B. | (Ordinary shares) | N/A |
(Preference shares) | N/A | |
(Other class) | N/A |
Page 4 of 13
Convertibles (i.e. Convertible into Shares of the Issuer which are to be Listed)
No. of new | No. of new | ||||||||||||
shares of | shares of | ||||||||||||
issuer | issuer which | ||||||||||||
issued | may be | ||||||||||||
during the | issued | ||||||||||||
month | pursuant | ||||||||||||
Amount at | pursuant | thereto as at | |||||||||||
Currency of | close of | Converted | Amount at | thereto | close of the | ||||||||
amount | preceding | during the | close of the | month | |||||||||
Class and description | outstanding | month | month | month | |||||||||
1. | N/A | ||||||||||||
Stock code (if listed) | ||||
Class of shares | ||||
issuable (Note 1) | ||||
Subscription price | ||||
EGM approval date | ||||
(if applicable) | ||||
(dd/mm/yyyy)) | ( / / | ) | ||
2. | N/A | |||
Stock code (if listed) | |||||||
Class of shares | |||||||
issuable (Note 1) | |||||||
Subscription price | |||||||
EGM approval date | |||||||
(if applicable) | |||||||
(dd/mm/yyyy) | ( / / | ) | |||||
3. | N/A | ||||||
Stock code (if listed) | |||||||
Class of shares | |||||||
issuable (Note 1) | |||||||
Subscription price | |||||||
EGM approval date | |||||||
(if applicable) | |||||||
(dd/mm/yyyy) | ( / / | ) | |||||
4. | N/A | ||||||
Stock code (if listed) | ||
Class of shares | ||
issuable (Note 1) | ||
Subscription price | ||
EGM approval date | ||
(if applicable) | ||
(dd/mm/yyyy) | ( / / | ) |
Total C. (Ordinary shares) | N/A |
(Preference shares) | N/A |
(Other class) | N/A |
Page 5 of 13
Any other Agreements or Arrangements to Issue Shares of the Issuer which are to be Listed, including Options (other than under Share Option Schemes)
No. of new shares | No. of new shares of | ||||||
of issuer issued | issuer which may be | ||||||
during the month | issued pursuant | ||||||
pursuant thereto | |||||||
thereto as at close of | |||||||
Full particulars including EGM approval date (dd/mm/yyyy), | the month | ||||||
if applicable, and class of shares issuable: | |||||||
1. | N/A | ||||||
( | / | / | ) | ||||
shares (Note 1) | |||||||
2. | N/A | ||||||
( | / | / | ) | ||||
shares (Note 1) | |||||||
3. | N/A | ||||||
( | / | / | ) | ||||
shares (Note 1) | |||||||
N/A | |||||||
Total D. (Ordinary shares) | |||||||
(Preference shares) | N/A | ||||||
(Other class) | N/A | ||||||
Page 6 of 13
Other Movements in Issued Share Capital
No. of new | No. of new | |||||||||||||
shares of | shares of | |||||||||||||
issuer | issuer which | |||||||||||||
issued | may be | |||||||||||||
during the | issued | |||||||||||||
month | pursuant | |||||||||||||
pursuant | thereto as at | |||||||||||||
thereto | close of the | |||||||||||||
Type of Issue | month | |||||||||||||
Class | of | shares | ________ | |||||||||||
issuable (Note 1) | ||||||||||||||
1. | Rights issue | At price : | State | Issue and allotment | ( | / | / | ) | ||||||
currency | date : (dd/mm/yyyy) | |||||||||||||
EGM approval date: | ( | / | / | ) | ||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Class | of | shares | ________ | |||||||||||
issuable (Note 1) | ||||||||||||||
2. | Open offer | At price : | State | Issue and allotment | ( | / | / | ) | ||||||
currency | date : (dd/mm/yyyy) | |||||||||||||
EGM approval date: | ( | / | / | ) | ||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Class | of | shares | ________ | |||||||||||
issuable (Note 1) | ||||||||||||||
3. | Placing | At price : | State | Issue and allotment | ( | / | / | ) | ||||||
currency | date : (dd/mm/yyyy) | |||||||||||||
EGM approval date: | ( | / | / | ) | ||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Class | of | shares | ________ | |||||||||||
issuable (Note 1) | ||||||||||||||
4. | Bonus issue | Issue and allotment | ( | / | / | ) | ||||||||
date : (dd/mm/yyyy) | ||||||||||||||
EGM approval date: | ( | / | / | ) | ||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Page 7 of 13
No. of new | No. of new | |||||||||||||
shares of | shares of | |||||||||||||
issuer | issuer which | |||||||||||||
issued | may be | |||||||||||||
during the | issued | |||||||||||||
month | pursuant | |||||||||||||
pursuant | thereto as at | |||||||||||||
thereto | close of the | |||||||||||||
Type of Issue | month | |||||||||||||
Class | of | shares | ________ | |||||||||||
issuable (Note 1) | ||||||||||||||
5. | Scrip dividend | At price : | State | Issue and allotment | ( | / | / | ) | ||||||
currency | date : (dd/mm/yyyy) | |||||||||||||
( | / | / | ) | |||||||||||
EGM approval date: | ||||||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Class | of | shares | ________ | |||||||||||
repurchased (Note 1) | ||||||||||||||
6. | Repurchase of | Cancellation date : | ( | / | / | ) | ||||||||
shares | (dd/mm/yyyy) | |||||||||||||
EGM approval date: | ( | / | / | ) | ||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Class | of | shares | ________ | |||||||||||
redeemed (Note 1) | ||||||||||||||
7. | Redemption of | Redemption date : | ( | / | / | ) | ||||||||
shares | (dd/mm/yyyy) | |||||||||||||
EGM approval date: | ( | / | / | ) | ||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Class | of | shares | ________ | |||||||||||
issuable (Note 1) | ||||||||||||||
8. | Consideration | At price : | State | Issue and allotment | ( | / | / | ) | ||||||
issue | currency | date : (dd/mm/yyyy) | ||||||||||||
( | / | / | ) | |||||||||||
EGM approval date: | ||||||||||||||
(dd/mm/yyyy) | N/A | N/A | ||||||||||||
Page 8 of 13
No. of new | No. of new | ||||||||||||||
shares of | shares of | ||||||||||||||
issuer | issuer which | ||||||||||||||
issued | may be | ||||||||||||||
during the | issued | ||||||||||||||
month | pursuant | ||||||||||||||
pursuant | thereto as at | ||||||||||||||
thereto | close of the | ||||||||||||||
Type of Issue | month | ||||||||||||||
Class | of | shares | ________ | ||||||||||||
issuable (Note 1) | |||||||||||||||
9. Capital | Issue and allotment | ( | / | / | ) | ||||||||||
reorganisation | date : (dd/mm/yyyy) | ||||||||||||||
EGM approval date: | ( | / | / | ) | |||||||||||
(dd/mm/yyyy) | N/A | N/A | |||||||||||||
Class | of | shares | ________ | ||||||||||||
issuable (Note 1) | |||||||||||||||
10. Other | At price : | State | Issue and allotment | ( | / | / | ) | ||||||||
(Please specify) | currency | ||||||||||||||
date : (dd/mm/yyyy) | |||||||||||||||
EGM approval date: | ( | / | / | ) | |||||||||||
(dd/mm/yyyy) | N/A | N/A | |||||||||||||
Total E. | (Ordinary | ||||||||||||||
shares) | N/A | ||||||||||||||
(Preference shares) | N/A | ||||||||||||||
(Other class) | N/A | ||||||||||||||
Total increase / (decrease) in ordinary shares during the month (i.e. Total of A to E): | (1) | 30,000 | |||||||||||||
(2) | N/A | ||||||||||||||
Total increase / (decrease) in preference shares during the month (i.e. Total of A to E): | N/A | ||||||||||||||
Total increase / (decrease) in other classes of shares during the month (i.e. Total of A to | N/A | ||||||||||||||
E): |
(These figures should be the same as the relevant figures under II above ("Movements in Issued Share Capital").)
Page 9 of 13
IV. Confirmations
We hereby confirm to the best knowledge, information and belief that, in relation to each of the securities issued by the issuer during the month as set out in Part III which has not been previously disclosed in a return published under rule 13.25A, it has been duly authorized by the board of directors of the listed issuer and, insofar as applicable:
(Note 2)
- all money due to the listed issuer in respect of the issue of securities has been received by it;
-
all pre-conditions for listing imposed by the Rules Governing the Listing of Securities on The
Stock Exchange of Hong Kong Limited under "Qualifications of listing" have been fulfilled; - all (if any) conditions contained in the formal letter granting listing of and permission to deal in the securities have been fulfilled;
- all the securities of each class are in all respects identical (Note 3);
- all documents required by the Companies (Winding Up and Miscellaneous Provisions) Ordinance to be filed with the Registrar of Companies have been duly filed and that compliance has been made with other legal requirements;
- all the definitive documents of title have been delivered/are ready to be delivered/are being prepared and will be delivered in accordance with the terms of issue;
- completion has taken place of the purchase by the issuer of all property shown in the listing document to have been purchased or agreed to be purchased by it and the purchase consideration for all such property has been duly satisfied; and
- the trust deed/deed poll relating to the debenture, loan stock, notes or bonds has been completed and executed, and particulars thereof, if so required by law, have been filed with the Registrar of Companies.
Page 10 of 13
Remarks (if any):
- Pursuant to the announcement of the Company dated 26 September 2016, 7,890,000 share options were granted on 26 September 2016 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity period as follows:
- 540,000 share options being exercisable in four equal tranches from 1 January 2017 to 31 December 2020; and
- 7,350,000 share options being exercisable in ten equal tranches from 1 January 2017 to 31 December 2026.
- Pursuant to the announcement of the Company dated 18 September 2017, 2,595,000 share options were granted on 18 September 2017 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity period as follows:
- 735,000 share options being exercisable in one tranche from 1 January 2027 to 17 September 2027; and
- 1,860,000 share options being exercisable in four equal tranches from 1 January 2018 to 31 December 2021.
- Pursuant to the announcement of the Company dated 5 December 2017, 300,000 share
options were granted on 5 December 2017 to entitle the holder(s) thereof to subscribe for
one (1) share for each share option, with validity period as follows:
- 100,000 share options being exercisable from 1 April 2018 to 4 December 2027;
- 100,000 share options being exercisable from 1 April 2019 to 4 December 2027; and
- 100,000 share options being exercisable from 1 April 2020 to 4 December 2027.
- Pursuant to the announcement of the Company dated 11 April 2018, 200,000 share options were granted on 11 April 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 50,000 share options being exercisable from 2 January 2019 to 31 December 2022;
- 50,000 share options being exercisable from 2 January 2020 to 31 December 2022;
- 50,000 share options being exercisable from 2 January 2021 to 31 December 2022; and
- 50,000 share options being exercisable from 2 January 2022 to 31 December 2022
- Pursuant to the announcement of the Company dated 17 April 2018, 60,000 share options were granted on 17 April 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 20,000 share options being exercisable from 2 January 2019 to 31 December 2021;
- 20,000 share options being exercisable from 2 January 2020 to 31 December 2021;and
- 20,000 share options being exercisable from 4 January 2021 to 31 December 2021
- Pursuant to the announcement of the Company dated 24 May 2018, 1,000,000 share options were granted on 24 May 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 100,000 share options being exercisable from 3 July 2018 to 23 May 2028;
- 200,000 share options being exercisable from 2 January 2019 to 23 May 2028;
- 300,000 share options being exercisable from 2 January 2020 to 23 May 2028; and
- 400,000 share options being exercisable from 4 January 2021 to 23 May 2028
- Pursuant to the announcement of the Company dated 10 July 2018, 100,000 share options were granted on 10 July 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 20,000 share options being exercisable from 2 January 2019 to 31 December 2023;
- 20,000 share options being exercisable from 2 January 2020 to 31 December 2023;
Page 11 of 13
- 20,000 share options being exercisable from 4 January 2021 to 31 December 2023;
- 20,000 share options being exercisable from 3 January 2022 to 31 December 2023; and
- 20,000 share options being exercisable from 2 January 2023 to 31 December 2023;
- Pursuant to the announcement of the Company dated 21 August 2018, 800,000 share options were granted on 21 August 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 275,000 share options being exercisable from 2 January 2019 to 20 August 2028;
- 275,000 share options being exercisable from 2 January 2020 to 20 August 2028;
- 125,000 share options being exercisable from 4 January 2021 to 20 August 2028;
- 125,000 share options being exercisable from 3 January 2022 to 20 August 2028;
- Pursuant to the announcement of the Company dated 7 September 2018, 100,000 share options were granted on 7 September 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 25,000 share options being exercisable from 2 January 2019 to 6 September 2028;
- 25,000 share options being exercisable from 2 January 2020 to 6 September 2028;
- 25,000 share options being exercisable from 4 January 2021 to 6 September 2028;
- 25,000 share options being exercisable from 3 January 2022 to 6 September 2028;
- Pursuant to the announcement of the Company dated 2 October 2018, 1,575,000 share options were granted on 2 October 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 210,000 share options being exercisable from 2 January 2019 to 1 October 2028;
- 210,000 share options being exercisable from 2 January 2020 to 1 October 2028;
- 210,000 share options being exercisable from 4 January 2021 to 1 October 2028;
- 210,000 share options being exercisable from 3 January 2022 to 1 October 2028;
- 735,000 share options being exercisable from 3 January 2028 to 1 October 2028;
- Pursuant to the announcement of the Company dated 28 November 2018, 1,620,000 share options were granted on 28 November 2018 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 30,000 share options being exercisable from 2 January 2019 to 27 November 2028;
- 130,000 share options being exercisable from 2 January 2020 to 27 November 2028;
- 230,000 share options being exercisable from 4 January 2021 to 27 November 2028;
- 430,000 share options being exercisable from 3 January 2022 to 27 November 2028;
- 400,000 share options being exercisable from 2 January 2023 to 27 November 2028;
- 300,000 share options being exercisable from 2 January 2024 to 27 November 2028;
- 100,000 share options being exercisable from 2 January 2025 to 27 November 2028;
- Pursuant to the announcement of the Company dated 2 July 2019, 150,000 share
options were granted on 2 July 2019 to entitle the holder(s) thereof to subscribe for
one (1) share for each share option, with validity periods as follows :
- 50,000 share options being exercisable from 2 January 2020 to 1 July 2023;
- 50,000 share options being exercisable from 4 January 2021 to 1 July 2023;
- 50,000 share options being exercisable from 3 January 2022 to 1 July 2023;
13. Pursuant to the announcement of the Company dated 12 July 2019, 1,000,000 share options were granted on 12 July 2019 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 250,000 share options being exercisable from 2 January 2020 to 11 July 2024;
- 250,000 share options being exercisable from 4 January 2021 to 11 July 2024;
Page 12 of 13
- 250,000 share options being exercisable from 3 January 2022 to 11 July 2024;
- 250,000 share options being exercisable from 2 January 2023 to 11 July 2024;
- Pursuant to the announcement of the Company dated 16 October 2019, 1,735,000 share options Were granted on 16 October 2019 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 200,000 share options being exercisable from 16 October 2019 to 15 October 2029;
- 50,000 share options being exercisable from 4 January 2021 to 15 October 2029;
- 100,000 share options being exercisable from 3 January 2022 to 15 October 2029;
- 150,000 share options being exercisable from 3 January 2023 to 15 October 2029;
- 500,000 share options being exercisable from 2 January 2024 to 15 October 2029;
- 735,000 share options being exercisable from 2 January 2029 to 15 October 2029;
- Pursuant to the announcement of the Company dated 8 November 2019, 150,000 share options Were granted on 8 November 2019 to entitle the holder(s) thereof to subscribe for one (1) share for each share option, with validity periods as follows :
- 150,000 share options being exercisable from vest in the Grantee immediately upon acceptance to 7 November 2029.
Submitted by: ________Siu Chun Pong Raymond__________
Title: ____________________Secretary_________________
(Director, Secretary or other duly authorised officer)
Notes :
- State the class of shares (e.g. ordinary, preference or other).
- Items (i) to (viii) are suggested forms of confirmation which may be amended to meet individual cases. Where the issuer has already made the relevant confirmations in a return published under rule 13.25A in relation to the securities issued, no further confirmation is required to be made in this return.
- "Identical" means in this context:
- the securities are of the same nominal value with the same amount called up or paid up;
- they are entitled to dividend/interest at the same rate and for the same period, so that at the next ensuing distribution,the dividend/interest payable per unit willamount to exactly the same sum (gross and net); and
- they carry the same rights as to unrestricted transfer, attendance and voting at meetings and rank pari passu in all other respects.
- If there is insufficient space, please append the prescribed continuation sheet.
Page 13 of 13
Attachments
- Original document
- Permalink
Disclaimer
Union Medical Healthcare Ltd. published this content on 05 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 March 2020 08:51:16 UTC